Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT04361409 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Carcinoma

Interventions

DRUG: Rituximab
DRUG: Cisplatin
DRUG: Gemcitabine

Sponsor

China Medical University Hospital